Evidence map›Paper›PMID 41569151›Full record

ArticleNucleic acids research2026

Structural plasticity enables broad cAn binding and dual activation of CRISPR-associated ribonuclease Cdn1.

Wenxuan Zhang, Jianping Kong, Yuqin Zeng, Yunning Su, Sijun Zhang, Yutao Li, Chunyi Hu, Qihua Chen, Yibei Xiao, Meiling Lu

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenxuan ZhangState Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.ORCID 0009-0006-5038-7313
Jianping KongState Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Yuqin ZengState Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Yunning SuDepartment of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.
Sijun ZhangDepartment of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.
Yutao LiState Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Chunyi HuDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore 117543, Singapore.ORCID 0000-0003-4509-4840
Qihua ChenDepartment of Neurology, the Second Xiangya Hospital, Central South University, Changsha 410008, China.
Yibei XiaoState Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0003-4716-5526
Meiling LuDepartment of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0001-8738-987X

Funding

National Key Research and Development Program of China 2023YFC3402300National Natural Science Foundation of China 31970547STI2030-Major Projects 2021ZD0203400
6 · The paper itself

Abstract

Prokaryotes have naturally evolved diverse RNA-guided defense systems against viral infections, with the type III CRISPR-Cas systems representing the most intricate. These systems feature accessory proteins activated by cyclic oligoadenylates (cOAs) produced upon target RNA recognition, synergizing with the CRISPR-Cas machinery to defend against exogenous invaders. Typically, each accessory protein is activated by only one specific cOA type. Here, we characterize Cdn1, a type III-B CRISPR accessory protein from Psychrobacter lutiphocae, which binds to cA3, cA4, and cA6, but activated by cA4 and cA6 with different efficacies to catalyze ssRNA cleavage. Combined structural and biochemical analyses reveal that cOA binding triggers dramatic conformational reorganization, including the formation of a dimerization interface of nuclease domains, the emergence of substrate binding cleft, and the reconstruction of a metal-dependent catalytic center essential for RNA cleavage. This dual activation mechanism illustrates evolutionary innovation within CRISPR-associated Rossman-fold nucleases. We propose that such structural plasticity evolved to maximize defensive resilience during microbial competition and horizontal gene transfer, while preserving broad-spectrum antiviral ability. These findings not only elucidate the activation mechanisms of Cdn1 within the type III systems but also underscore the functional complexity and adaptability of CRISPR-Cas ancillary proteins.

Indexed as

Bacterial ProteinsCRISPR-Associated ProteinsCRISPR-Cas SystemsAdenine NucleotidesCatalytic DomainModels, MolecularOligoribonucleotidesProtein BindingRNA Cleavage2',5'-oligoadenylateAdenine NucleotidesBacterial ProteinsCRISPR-Associated ProteinsOligoribonucleotides

Identifiers

PMID41569151
PMCPMC12825302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.